Advertisement

Spinal Tech

Advertisement

BioMimetic Therapeutics recently announced financial results for the fourth quarter of 2011, where it reported total revenue of $458,300, an increase over the same period last year.

Data from the National Joint Registry of England and Wales shows that metal-on-metal stemmed articulations often have poor survival rates, according to an article published in The Lancet.

Advertisement